An open-label, multicenter phase I/IIa study evaluating the safety and clinical activity of clonal neoantigen reactive T cells in patients with advanced non-small cell lung cancer (CHIRON).

Mariam Jamal‐Hanjani, Martin Förster, Fiona Thistlethwaite et al.|Journal of Clinical Oncology|2021

Cited by 5